Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Fagron NV
FAGRFagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium. Address: Venecoweg 20A, Nazareth, Belgium, 9810
Analytics
Objectif de Cours de WallStreet
20.58 EURRatio C/B
17.9626Rendement du dividende
1.67 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés FAGR
Analyse des dividendes FAGR
Croissance des dividendes sur 5 ans
150 %Croissance continue
3 annéesRatio de distribution Moyenne sur 5 ans
18 %Historique des dividendes FAGR
Valorisation des titres FAGR
financières FAGR
Résultats | 2019 | Dynamique |